BPC-157 & TB-500 Blend (Research-Grade Peptides)
Regenerative peptide combination — for laboratory research only
Product Overview
The BPC-157 and TB-500 blend combines two widely studied research peptides with potential roles in tissue repair and recovery. BPC-157 (Body Protection Compound 157) is a synthetic peptide fragment derived from a gastric protein, while TB-500 (Thymosin Beta-4 fragment) is a synthetic sequence associated with actin regulation. Together, they are provided here as a research-grade formulation for preclinical and laboratory investigation into regenerative pathways.
Research Highlights
- Tissue Repair Studies: BPC-157 has been explored in animal models for potential effects on tendon, ligament, and gastrointestinal tissue recovery. PubMed
- Angiogenesis & Cell Migration: TB-500 has been studied for its involvement in angiogenesis, wound healing, and cell migration mechanisms. PubMed
- Synergistic Investigations: Preclinical interest exists in combining these peptides to better understand overlapping regenerative and cytoprotective pathways.
- Ongoing Areas of Study: Research continues on their potential applications in musculoskeletal recovery, inflammation modulation, and vascular biology.
Product Details & Handling
- Form: Lyophilized peptide powder, sterile vials
- Purity: ≥ 98% (Certificate of Analysis provided)
- Storage: Store at –20 °C; protect from light and moisture
- Handling: Laboratory use only with appropriate PPE; consult SDS for full safety guidance
Legal Disclaimer
This product is provided strictly for laboratory research use only. It is not intended for human or veterinary consumption, therapeutic, diagnostic, or clinical application. Customers are responsible for ensuring compliance with applicable laws and institutional requirements. The BPC-157/TB-500 blend is not approved by the FDA in research form, and Windy City Peptide does not provide medical advice or support for human use.